us-abfm MCQ (SBA): MASLD Lifestyle Therapy

Instant feedback + full explanation. One question, done properly.

ModerateGastroenterologyMASLD Lifestyle Therapyus-abfmus-abimus-usmle-step-2

A 62-year-old with insulin-treated type 2 diabetes and BMI 33 kg/m² has steatotic liver disease (FIB-4 indeterminate). Which lifestyle target is most strongly associated with NASH histologic improvement?

Educational content. Not a substitute for clinical judgement or local policy.

us-abfm MCQ: MASLD Lifestyle Therapy — Answer & Explanation | iatroX